Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021;57(4):410-416.
doi: 10.1007/s10593-021-02917-3. Epub 2021 May 12.

Recent advances on heterocyclic compounds with antiviral properties

Affiliations

Recent advances on heterocyclic compounds with antiviral properties

Aramita De et al. Chem Heterocycl Compd (N Y). 2021.

Abstract

In recent years several important viral infections have emerged and antiviral chemotherapeutic agents are not sufficiently effective in clinic, leading to serious human diseases and mortality. Therefore, novel antiviral candidates are urgently desirable, which undoubtedly is essential for the therapy of various fatal and debilitating viral infections. Heterocyclic compounds are obtaining importance in the field of medicinal chemistry because of the broad spectrum of their physiological activities. Among N- and S-containing heterocycles, indole, imidazole, thiazole, pyridine, and quinaxoline derivatives are especially attractive. The present review highlights antiviral behavior of these heterocyclic compounds.

Keywords: antiviral activity; biological activity; cytotoxicity; virus.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Derivatives of indole and isoindole.
Figure 2.
Figure 2.
Derivatives of pyrazole, imidazole, indazole, and imidazopyridine.
Figure 3.
Figure 3.
Derivatives of thiazole.
Figure 4.
Figure 4.
Derivatives of triazole, oxadiazole, and thiadiazole.
Figure 5.
Figure 5.
Derivatives of pyridine and pyrimidine.
Figure 6.
Figure 6.
Derivatives of quinazoline and quinoxaline.

Similar articles

Cited by

References

    1. Eg S, Lakshmanan B, Asian J. Pharm. Clin. Res. 2020;13:30.
    1. Furuyama W, Marzi A. Annu. Rev. Virol. 2019;6:435. doi: 10.1146/annurev-virology-092818-015708. - DOI - PubMed
    1. Musso D, Ko AI, Baud DN. Engl. J. Med. 2019;381:1444. doi: 10.1056/NEJMra1808246. - DOI - PubMed
    1. (a) El-Sebaey, S. A. ChemistrySelect2020, 5, 11654. (b) Wang, M.; Cao, R.; Zhang, L.; Yang, X.; Liu, J.; Xu, M.; Shi, Z.; Hu, Z.; Zhong, W.; Xiao, G. Cell Res.2020, 30, 269. - PMC - PubMed
    1. Gilbert C, Bestman-Smith J, Boivin G. Drug Resist. Updates. 2002;5:88. doi: 10.1016/S1368-7646(02)00021-3. - DOI - PubMed